| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f34119b232d292c72e632b62008eca90 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-05 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-05 |
| filingDate |
1996-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8965980a88872b1c5b1464b89140b13e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a23878e0d878bff9fb9fd741fd8122c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_369a246c0fda931cfafd5754397f2191
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c1c7abd65e4e91ad67daf92165e55e8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a9851936f7bfc93c40fb35ebf98be9d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a9fcca2e9eb2e5161f5655cad00c7519 |
| publicationDate |
1997-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CA-2189713-A1 |
| titleOfInvention |
Intramuscular Stimulation Lead with Enhanced Infection Resistance |
| abstract |
To minimize the incidence and consequences of device related infection that occur after prosthetics implants of neuro-muscular stimulating devices, an infection resistant intra-muscular lead has been developed and is disclosed herein. Infection incidence has been decreased by using biomaterials able to release antibacterial drugs (gentamicin) at a controlled rate for the first 3-6 weeks after implant. |
| priorityDate |
1995-11-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |